Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 111592553 | 11159255 | 3 | F | 20131125 | 20160823 | 20150603 | 20160830 | EXP | JP-GLAXOSMITHKLINE-JP2015JPN000269 | GLAXOSMITHKLINE | 38.38 | YR | F | Y | 57.00000 | KG | 20160830 | CN | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 111592553 | 11159255 | 1 | PS | LAMICTAL | LAMOTRIGINE | 1 | Oral | 25 MG, QD | 375 | MG | Y | 20241 | 25 | MG | TABLET | QD | |||
| 111592553 | 11159255 | 2 | SS | LAMICTAL | LAMOTRIGINE | 1 | Oral | 50 MG, QD | 375 | MG | Y | 20241 | 50 | MG | TABLET | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 111592553 | 11159255 | 1 | Depression |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 111592553 | 11159255 | HO |
| 111592553 | 11159255 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 111592553 | 11159255 | Apoptosis | |
| 111592553 | 11159255 | Conjunctival hyperaemia | |
| 111592553 | 11159255 | Conjunctivitis | |
| 111592553 | 11159255 | Corneal disorder | |
| 111592553 | 11159255 | Enanthema | |
| 111592553 | 11159255 | Epidermal necrosis | |
| 111592553 | 11159255 | Erythema | |
| 111592553 | 11159255 | Erythema of eyelid | |
| 111592553 | 11159255 | Eye discharge | |
| 111592553 | 11159255 | Eyelid erosion | |
| 111592553 | 11159255 | Hypophagia | |
| 111592553 | 11159255 | Lip erosion | |
| 111592553 | 11159255 | Oral mucosa erosion | |
| 111592553 | 11159255 | Oral mucosal eruption | |
| 111592553 | 11159255 | Oropharyngeal pain | |
| 111592553 | 11159255 | Perivascular dermatitis | |
| 111592553 | 11159255 | Pyrexia | |
| 111592553 | 11159255 | Rash | |
| 111592553 | 11159255 | Rash maculo-papular | |
| 111592553 | 11159255 | Scab | |
| 111592553 | 11159255 | Stevens-Johnson syndrome | |
| 111592553 | 11159255 | Vulvovaginal erythema |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 111592553 | 11159255 | 1 | 20131112 | 20131121 | 0 | |
| 111592553 | 11159255 | 2 | 20131122 | 20131127 | 0 |